Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.61 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 3/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | HPGD | P15428 | 4/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7204874 | 0.88 | CYP2C9 (0.56) | CYP2C9CYP2C19MEN1KMT2AHPGD | |
| SCHEMBL13501913 | 0.85 | MEN1 (0.56) | CYP2C9CYP2C19MEN1KMT2AHPGD | |
| SCHEMBL13502124 | 0.83 | CYP2C9 (0.52) | CYP2C9CYP2C19MEN1KMT2AHPGD | |
| SCHEMBL8444032 | 0.81 | PTGS1 (0.65) | CYP2C9CYP2C19MEN1KMT2AHPGD | |
| SCHEMBL6448837 | 0.78 | HCRTR1 (0.46) | CYP2C9CYP2C19MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL8635567 | 0.76 | PTGS1 (0.55) | CYP2C9CYP2C19MEN1KMT2AHPGD | |
| SCHEMBL27410012 | 0.75 | CYP2C9 (0.50) | CYP2C9CYP2C19MEN1KMT2AHPGD | |
| SCHEMBL27389982 | 0.75 | CYP2C9 (0.53) | CYP2C9CYP2C19MEN1KMT2AHPGD | |
| SCHEMBL13817414 | 0.75 | CYP2C9 (0.45) | CYP2C9CYP2C19MEN1KMT2AHPGD | |
| SCHEMBL3551478 | 0.75 | MAPT (0.51) | CYP2C9CYP2C19MEN1KMT2AHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090143446-A1 | THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, METHODS OF MAKING, AND USES THEREOF | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2009-06-04 | — | — | US | claimed |
| EP-1692121-A1 | THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, METHODS OF MAKING, AND USES THEREOF | University of Tennessee Research Foundation (US) | 2006-08-23 | — | — | EP | claimed |
| US-20060040998-A1 | Thiazolidinone amides, thiazolidine carboxylic acid amides, methods of making, and uses thereof | THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2006-02-23 | — | — | US | claimed |
| WO-2005049591-A1 | THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, METHODS OF MAKING, AND USES THEREOF | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2005-06-02 | — | — | WO | claimed |
| US-7662842-B2 | Thiazolidinone amides, thiazolidine carboxylic acid amides, and serine amides, including polyamine conjugates thereof, as selective anti-cancer agents | Ohio State Univesity Research Foundation (US) | 2010-02-16 | — | — | US | disclosed |
| US-20090143446-A1 | THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, METHODS OF MAKING, AND USES THEREOF | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2009-06-04 | — | — | US | disclosed |
| WO-2008128179-A1 | THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, AND SERINE AMIDES, INCLUDING POLYAMINE CONJUGATES THEREOF, AS SELECTIVE ANTI-CANCER AGENTS | THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2008-10-23 | — | — | WO | disclosed |
| US-20080255213-A1 | THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, AND SERINE AMIDES, INCLUDING POLYAMINE CONJUGATES THEREOF, AS SELECTIVE ANTI-CANCER AGENTS | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2008-10-16 | — | — | US | disclosed |
| EP-1926487-A2 | THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, AND SERINE AMIDES, INCLUDING POLYAMINE CONJUGATES THEREOF, AS SELECTIVE ANTI-CANCER AGENTS | University of Tennessee Research Foundation (US) | 2008-06-04 | — | — | EP | disclosed |
| WO-2008036067-A2 | THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, AND SERINE AMIDES, INCLUDING POLYAMINE CONJUGATES THEREOF, AS SELECTIVE ANTI-CANCER AGENTS | THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2008-03-27 | — | — | WO | disclosed |
| US-7307093-B2 | Cancer, selectivity to prostate cancer cell lines, ovarian cancer cells | THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2007-12-11 | — | — | US | disclosed |
| US-20070155807-A1 | THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, AND SERINE AMIDES, INCLUDING POLYAMINE CONJUGATES THEREOF, AS SELECTIVE ANTI-CANCER AGENTS | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2007-07-05 | — | — | US | disclosed |
| US-20070155807-A1 | THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, AND SERINE AMIDES, INCLUDING POLYAMINE CONJUGATES THEREOF, AS SELECTIVE ANTI-CANCER AGENTS | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2007-07-05 | — | — | US | disclosed |
| EP-1723127-A2 | ANALOGS EXHIBITING INHIBITION OF CELL PROLIFERATION, METHODS OF MAKING, AND USES THEREOF | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2006-11-22 | — | — | EP | disclosed |
| EP-1692121-A1 | THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, METHODS OF MAKING, AND USES THEREOF | University of Tennessee Research Foundation (US) | 2006-08-23 | — | — | EP | disclosed |
| US-20060040998-A1 | Thiazolidinone amides, thiazolidine carboxylic acid amides, methods of making, and uses thereof | THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2006-02-23 | — | — | US | disclosed |
| US-20060014740-A1 | Analogs exhibiting inhibition of cell proliferation, methods of making, and uses thereof | US GOVERNMENT - SECRETARY FOR THE ARMY | 2006-01-19 | — | — | US | disclosed |
| WO-2005086638-A2 | ANALOGS EXHIBITING INHIBITION OF CELL PROLIFERATION, METHODS OF MAKING, AND USES THEREOF | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2005-09-22 | — | — | WO | disclosed |
| WO-2005049591-A1 | THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, METHODS OF MAKING, AND USES THEREOF | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2005-06-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090143446-A1 | THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, METHODS OF MAKING, AND USES THEREOF | NAT1, AADAC, PPARG | CYP2C9 109/4885CYP2C19 232/4885SIGMAR1 1987/4885 |
| US-20060014740-A1 | Analogs exhibiting inhibition of cell proliferation, methods of making, and uses thereof | MKI67, MCL1, API5 | CYP2C9 3506/4885CYP2C19 2735/4885SIGMAR1 4258/4885 |
| US-20060040998-A1 | Thiazolidinone amides, thiazolidine carboxylic acid amides, methods of making, and uses thereof | NAT1, AADAC, PPARG | CYP2C9 109/4885CYP2C19 232/4885SIGMAR1 1987/4885 |
| US-20080255213-A1 | THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, AND SERINE AMIDES, INCLUDING POLYAMINE CONJUGATES THEREOF, AS SELECTIVE ANTI-CANCER AGENTS | SRM, SAT1, SMS | CYP2C9 3715/4885CYP2C19 3591/4885SIGMAR1 1073/4885 |
| US-20070155807-A1 | THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, AND SERINE AMIDES, INCLUDING POLYAMINE CONJUGATES THEREOF, AS SELECTIVE ANTI-CANCER AGENTS | SRM, SAT1, SMS | CYP2C9 2579/4885CYP2C19 2436/4885SIGMAR1 938/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.